These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36804488)

  • 1. Plasma and cerebrospinal fluid inflammatory markers and human aggression.
    Coccaro EF; Lee R; Breen EC; Irwin MR
    Neuropsychopharmacology; 2023 Jun; 48(7):1060-1066. PubMed ID: 36804488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.
    Coccaro EF; Lee R; Breen EC; Irwin MR
    Psychiatry Res; 2015 Oct; 229(3):844-9. PubMed ID: 26277033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary cortisol awakening levels are reduced in human subjects with intermittent explosive disorder compared with controls.
    Meruelo AD; Timmins MA; Irwin MR; Coccaro EF
    Psychoneuroendocrinology; 2023 May; 151():106070. PubMed ID: 36863129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study.
    Coccaro EF; Lee R; Coussons-Read M
    J Neural Transm (Vienna); 2015 Feb; 122(2):321-6. PubMed ID: 25056708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans.
    Coccaro EF; Lee R; Coussons-Read M
    JAMA Psychiatry; 2014 Feb; 71(2):158-65. PubMed ID: 24352431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Plasma Oxidative Stress Markers in Individuals With Intermittent Explosive Disorder and Correlation With Aggression in Humans.
    Coccaro EF; Lee R; Gozal D
    Biol Psychiatry; 2016 Jan; 79(2):127-35. PubMed ID: 24582164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical correlates of intermittent explosive disorder in Turkish psychiatric outpatients.
    Gelegen V; Tamam L
    Compr Psychiatry; 2018 May; 83():64-70. PubMed ID: 29604524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid intermittent explosive disorder and posttraumatic stress disorder: Clinical correlates and relationship to suicidal behavior.
    Fanning JR; Lee R; Coccaro EF
    Compr Psychiatry; 2016 Oct; 70():125-33. PubMed ID: 27624432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity.
    Coccaro EF; Fridberg DJ; Fanning JR; Grant JE; King AC; Lee R
    J Psychiatr Res; 2016 Oct; 81():127-32. PubMed ID: 27442963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.
    Coccaro EF; Lee R; Kavoussi RJ
    J Psychiatr Res; 2010 Feb; 44(3):137-42. PubMed ID: 19767013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The experience of aggressive outbursts in Intermittent Explosive Disorder.
    Kulper DA; Kleiman EM; McCloskey MS; Berman ME; Coccaro EF
    Psychiatry Res; 2015 Feb; 225(3):710-5. PubMed ID: 25541537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity of personality disorder with intermittent explosive disorder.
    Coccaro EF; Shima CK; Lee RJ
    J Psychiatr Res; 2018 Nov; 106():15-21. PubMed ID: 30240963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample.
    Coccaro EF; Fanning JR; Lee R
    J Clin Psychiatry; 2017 Jun; 78(6):697-702. PubMed ID: 28252880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.
    Coccaro EF; Lee R; Kavoussi RJ
    Neuropsychopharmacology; 2010 Jan; 35(2):435-44. PubMed ID: 19776731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder.
    Lee R; Ferris C; Van de Kar LD; Coccaro EF
    Psychoneuroendocrinology; 2009 Nov; 34(10):1567-73. PubMed ID: 19577376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social desirability, deceptive reporting, and awareness of problematic aggression in intermittent explosive disorder compared with non-aggressive healthy and psychiatric controls.
    Steakley-Freeman DM; Lee RJ; McCloskey MS; Coccaro EF
    Psychiatry Res; 2018 Dec; 270():20-25. PubMed ID: 30243128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social cognition in Intermittent Explosive Disorder and aggression.
    Coccaro EF; Fanning JR; Keedy SK; Lee RJ
    J Psychiatr Res; 2016 Dec; 83():140-150. PubMed ID: 27621104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid inflammatory cytokines and aggression in personality disordered subjects.
    Coccaro EF; Lee R; Coussons-Read M
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv001. PubMed ID: 25650410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSM-5 intermittent explosive disorder: Relationship with Disruptive Mood Dysregulation Disorder.
    Coccaro EF
    Compr Psychiatry; 2018 Jul; 84():118-121. PubMed ID: 29753187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.